Better Science, Better Health: New Healthcare Models

twitter-bird-bsbh-small Join the conversation on twitter #BSBH15

Agenda:

October 26th, 2015, Washington DC
Hotel George
7:00 pm Cocktail Reception

Kindly sponsored by Pfizer & DIA
October 27th, 2015, Washington DC
Cannon House Office Building, Cannon Caucas Room
8:00- 9:00 am Registration
9:00 – 10:30 am Opening Keynote Session: International Collaboration for Better Healthcare

  • Sheldon Whitehouse, United States Senator for Rhode Island
  • Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency
  • Lynn D. Hudson, Chief Science Officer, Critical Path Institute
  • Pierre Meulien, Executive Director, Innovative Medicines Initiative
  • Kenneth Oye, Associate Professor of Political Science and Engineering Systems, MIT (Moderator)
  • Sarah Garner, Associate Director Science Policy and Research, National Institute for Health and Clinical Excellence (NICE) (moderator)
10:30 – 11.00 am Coffee
11:00 – 12:30 pm Fostering Collaboration to Accelerate Better Patient Outcomes

  • John Wubbe, Secretary General & CEO, EPOSSI
  • Peter Saltonstall, CEO, National Organization of Rare Disorders, NORD
  • Pat Furlong, Founding President & CEO, Parent Project Muscular Dystrophy
  • Anders Olauson, President, European Patients’ Forum
  • Alastair Kent, Director, Genetic Alliance UK (moderator)
12:30 – 1:30 pm Networking lunch

  • Nancy Berg, CEO, ISPOR

Kindly sponsored by ISPOR
1:30 – 3:00 pm New Data Models: Managing Uncertainty and Leveraging New Sources of Evidence

  • Sabine Atzor, Director Regulatory Affairs, part time seconded from F.Hoffmann-La Roche to EFPIA
  • Kenneth Oye, Associate Professor of Political Science and Engineering Systems, MIT
  • Bettina Ryll, Founder, Melanoma Patient Network
  • Arti K. Rai, Elvin R. Latty Professor of Law, Duke Law Center for Innovation Policy
  • Duane Schulthess, Managing Director, Vital Transformation (moderator)
3:00 – 3:30 pm Coffee
3:30 – 5:00 pm Implementing Personalized Medicine, Determining Economic Value

  • Laura Esserman, Professor of Surgery and Radiology, Director UCSF Carol Franc Buck Breast Care Center
  • Richard Barker, Founding Director, CASMI
  • Mark Trusheim, Executive-in-Residence, MIT
  • Amy Miller, Executive VP, Personalized Medicine Coalition
  • Joseph Hammang, Partner, Vital Transformation (moderator)
7:00 pm Networking Dinner – Folger Shakespeare Library

  • David A. Dworaczyk, Director, Life and Health Sciences Strategic Development, Oracle Health Sciences
  • Ruxandra Draghia-Akli, Director Health, DG Research and Innovation, European Commission
  • Ryan Hohman, Friends of Cancer Research
  • Michael Burgess, US Congressman

Kindly sponsored by Oracle Health Sciences
October 28th, 2015, Washington DC
Capitol Visitor Centre, US House of Representatives Meeting Room HVC201
9:00 – 10:30 am Next Generation Innovations in Regulatory Science

  • Gigi Hirsch, Executive Director, MIT Center for Biomedical Innovation; Program Director, NEWDIGS
  • Alastair Kent, Director, Genetic Alliance UK
  • Carol Linden, Director Office of Regulatory Science and Innovation, FDA
  • Sandra Milligan, Senior Vice President and Head of Global Regulatory Affairs and Clinical Safety, Merck
  • Barbara Lopez Kunz, CEO, DIA (moderator)
10:30 – 11:00 am Coffee
11:00 – 12:30 pm Real World Evidence: Moving Beyond the Hype

  • Sarah Garner, Associate Director Science Policy and Research, National Institute for Health and Clinical Excellence (NICE)
  • Jeff Brown, Associate Professor, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
  • Adam Heathfield, Senior Director Global Health and Value Innovation Center, Pfizer
  • Mark Pearson, Deputy Director, Directorate of Employment, Labour and Social Affairs, OECD
  • Jonathan Sheldon, Global Vice President Healthcare, Oracle Health Sciences
  • Anders Olauson, President, European Patients’ Forum (moderator)
12:30 – 01:30 pm Networking Lunch
01:30 – 03:00 pm New Models for Patient Engagement: Improving Research Participation

  • Dainius Pavalkis, Professor, Lithuanian University of Health Sciences
  • Vicki Seyfert-Margolis, CEO, My Own Med, Inc.
  • Bart Vannieuwenhuyse, Senior Director Health Information Sciences, Janssen Pharmaceuticals
  • Jocelyn Ulrich, Director Scientific and Regulatory Affairs, PhRMA
  • Alastair Kent, Director, Genetic Alliance UK (moderator)
3:15 pm Closing address

  • Bill Cassidy, M.D., United States Senator for Louisiana
4:00 pm Cocktail Reception

Supported by:

Sponsored by: